Procyrion Inc.
Catheter-based micropump for ambulatory heart failure treatment
This article was originally published in Start Up
Executive Summary
Procyrion Inc. has developed a circulatory assist device for prolonged, ambulatory treatment of heart failure patients. Its Aortix is a micropump that is mounted on the tip of a catheter and placed nonsurgically in the descending thoracic aorta, where it reduces the heart's workload while increasing blood flow to kidneys and other organs.
You may also be interested in...
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
OIG: FDA’s EUA Approach Allowed Bad Tests To Reach Market
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.
TCT 2022: Trial Of Boston Scientific’s TAVR Embolic Protector Misses Endpoint, But May Offer 'Hope'
New trial data shows Boston Scientific’s Sentinel cerebral embolic protection device may reduce the risk of disabling stroke, but it does not appear to reduce the overall risk of stroke.